Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Using emergency funds to pay off credit card debt can be tempting but may leave you vulnerable. Weigh the pros and cons to make the best decision.
23,601 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A high-profile insider sale at LegalZoom has investors asking questions. This article breaks down what the move could...
Inflation drives rising demand on food banks and affordable-housing providers as low-income families struggle with hi...
In a world of rapid leadership shifts, Warren Buffett just reaffirmed his stance on Apple as a core holding. This art...
As AI investment accelerates, the capex question every holder for QQQ becomes central. The article examines how AI-dr...
Institutional landlords are stepping up the sale of single-family rentals as the ROAD Act takes effect. Early data sh...
A newly unsealed set of court filings details a 'honey-trap' scheme targeting a tech-family circle, underscoring how ...
New Mexico moves to examine decades of coerced sterilizations in Native communities, with findings due by 2027. The i...
When figma stock popped today, investors watched for catalysts beyond a single headline. This guide breaks down the d...
As millions approach 65, Medicare enrollment missteps can trigger permanent penalties that erode retirement budgets. ...
A JPMorgan note argues that a U.S. crypto market structure bill could pass by June and act as a positive catalyst for...
JPMorgan CEO Jamie Dimon dismissed Donald Trump’s $5 billion debanking lawsuit as meritless, but said he understands ...